Table 3.
Relationships between SUVmax1, ΔSUVmax%, and clinicopathological parameters.
| Parameter | No. of Cases N = 72 |
SUVmax1 | ΔSUVmax% | Group A vs. Group B | Group C vs. Group D | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High N = 19 |
Low N = 53 |
p-Value | High N = 37 |
Low N = 35 |
p-Value | Group A N = 13 |
Group B N = 59 |
p-Value | Group C N = 43 |
Group D N = 29 |
p-Value | ||
| Pathological T factor | |||||||||||||
| T1,2 | 3 (4%) | 0 (0%) | 3 (4%) | 0.17 | 1 (1%) | 2 (3%) | 0.52 | 0 (0%) | 3 (4%) | 0.29 | 1 (1%) | 2 (3%) | 0.35 |
| T3,4 | 69 (96%) | 19 (26%) | 50 (69%) | 36 (50%) | 33 (46%) | 13 (18%) | 56 (78%) | 42 (58%) | 27 (3 8%) | ||||
| Pathological N factor | |||||||||||||
| Positive | 58 (81%) | 8 | 40 (56%) | 0.044 | 29 (40%) | 29 (40%) | 0.63 | 12 (17%) | 46 (64%) | 0.20 | 35 (47%) | 23 (32%) | 0.83 |
| Negative | 14 (19%) | 1 (1%) | 13 (18%) | 8 (11%) | 6 (8%) | 1 (1%) | 13 (18%) | 8 (11%) | 6 (8%) | ||||
| Lymphatic permeation | |||||||||||||
| Positive | 64 (89%) | 19 (26%) | 45 (63%) | 0.022 | 34 (47%) | 30 (42%) | 0.40 | 13 (18%) | 51 (71%) | 0.065 | 40 (56%) | 24 (33%) | 0.18 |
| Negative | 8 (11%) | 0 (0%) | 8 (11%) | 3 (4%) | 5 (7%) | 0 (0%) | 8 (11%) | 3 (4%) | 5 (7%) | ||||
| CA19-9 | |||||||||||||
| >512 | 20 (28%) | 9 (13%) | 11 (15%) | 0.031 | 12 (17%) | 8 (11%) | 0.36 | 8 (11%) | 12 (17%) | 0.0043 | 13 (18%) | 7 (10%) | 0.57 |
| <512 | 52 (72%) | 10 (14%) | 42 (58%) | 25 (35%) | 27 (36%) | 5 (7%) | 47 (65%) | 30 (42%) | 22 (31%) | ||||
| Residual tumor | |||||||||||||
| R0 | 63 (88%) | 16 (22%) | 47 (65%) | 0.62 | 32 (44%) | 31 (43%) | 0.79 | 10 (14%) | 53 (74%) | 0.23 | 38 (53%) | 25 (38%) | 0.79 |
| R1 | 9 (13%) | 3 (4%) | 6 (8%) | 5 (7%) | 4 (6%) | 3 (4%) | 6 (8%) | 5 (7%) | 4 (6%) | ||||
| Completed adjuvant chemotherapy | |||||||||||||
| Yes | 36 (50%) | 8 (11%) | 28 (39%) | 0.42 | 12 (17%) | 24 (33%) | 0.0019 | 4 (6%) | 32 (44%) | 0.12 | 16 (22%) | 20 (28%) | 0.0076 |
| No | 36 (50%) | 11 (15%) | 25 (38%) | 25 (38%) | 11 (15%) | 9 (13%) | 27 (38%) | 27 (38%) | 9 (13%) | ||||
SUV, standardized uptake value; PPV, positive predictive value; NPV, negative predictive value; group A, high SUVmax1 and high ΔSUVmax%; group B, and others except A; group C, SUVmax1 and/or ΔSUVmax%; group D, and others except C. Values in bold are statistically significant.